These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose. Matsunari I, Böning G, Ziegler SI, Nekolla SG, Stollfuss JC, Kosa I, Ficaro EP, Schwaiger M. J Am Coll Cardiol; 1998 Oct; 32(4):927-35. PubMed ID: 9768713 [Abstract] [Full Text] [Related]
4. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging. Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, Salvadori PA, Pisani P, L'abbate A. J Nucl Cardiol; 2004 Oct; 11(2):142-51. PubMed ID: 15052245 [Abstract] [Full Text] [Related]
5. Assessment of myocardial viability in dysfunctional myocardium by resting myocardial blood flow determined with oxygen 15 water PET. Nowak B, Schaefer WM, Koch KC, Kaiser HJ, Block S, Knackstedt C, Zimny M, vom Dahl J, Buell U. J Nucl Cardiol; 2003 Oct; 10(1):34-45. PubMed ID: 12569329 [Abstract] [Full Text] [Related]
6. Prediction of functional improvement of ischemic myocardium with (123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: a study of patients with large acute myocardial infarction and receiving revascularization therapy. Seki H, Toyama T, Higuchi K, Kasama S, Ueda T, Seki R, Hatori T, Endo K, Kurabayashi M. Circ J; 2005 Mar; 69(3):311-9. PubMed ID: 15731537 [Abstract] [Full Text] [Related]
7. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch. Schaefer WM, Nowak B, Kaiser HJ, Koch KC, Block S, vom Dahl J, Buell U. J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874 [Abstract] [Full Text] [Related]
9. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability. Roes SD, Kaandorp TA, Marsan NA, Westenberg JJ, Dibbets-Schneider P, Stokkel MP, Lamb HJ, van der Wall EE, de Roos A, Bax JJ. Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):594-601. PubMed ID: 19050879 [Abstract] [Full Text] [Related]
14. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study. Liu M, Ma Z, Guo X, Zhu J, Su J. Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075 [Abstract] [Full Text] [Related]
17. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT. Slart RH, Bax JJ, Sluiter WJ, van Veldhuisen DJ, Jager PL. J Nucl Cardiol; 2004 Jan; 11(6):689-96. PubMed ID: 15592192 [Abstract] [Full Text] [Related]
18. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction. Raja S, Mittal BR, Santhosh S, Bhattacharya A, Rohit MK. Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559 [Abstract] [Full Text] [Related]
19. [An approach for comparative quantification of myocardial blood flow (O-15-H2O-PET), perfusion (Tc-99m-tetrofosmin-SPECT) and metabolism (F-18-FDG-PET)]. Schäfer WM, Nowak B, Kaiser HJ, Block S, Koch KC, vom Dahl J, Büll U. Nuklearmedizin; 2001 Oct; 40(5):164-71. PubMed ID: 11727629 [Abstract] [Full Text] [Related]